Watchlist Price Alert

Freeline Therapeutics (FRLN)

NASDAQ: FRLN · Real-Time Price · USD

6.49

0.01 (0.15%)

At close: Feb 16, 2024, 8:37 PM

Freeline Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-88.97M	-140.39M	-96.32M	-53.91M	-33.28M
Depreciation & Amortization	1.74M	2.39M	1.91M	1.54M	970K
Stock-Based Compensation	5.08M	10.72M	6.2M	1.46M	114K
Other Working Capital	3.62M	22.54M	-8.13M	-5.55M	-1.16M
Other Non-Cash Items	-4.98M	148K	76K	4.56M	n/a
Deferred Income Tax	-156K	-171K	-158K	-4.56M	n/a
Change in Working Capital	9.07M	19.74M	-6.68M	-1.41M	6.43M
Operating Cash Flow	-78.22M	-107.56M	-94.97M	-52.32M	-25.77M
Capital Expenditures	-7.01M	-4.27M	-2.51M	-3.02M	-3.75M
Cash Acquisitions	n/a	n/a	126.98K	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-980	n/a	n/a
Investing Cash Flow	-7.01M	-4.27M	-2.39M	-3.02M	-3.75M
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	27.52M	-984K	242.62M	114.59M	38.13M
Financial Cash Flow	27.52M	-984K	242.62M	114.59M	38.13M
Net Cash Flow	-70.46M	-112.51M	157M	58.23M	7.8M
Free Cash Flow	-85.24M	-111.83M	-97.48M	-55.34M	-29.52M